Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month's issue covers relevant news from November 2019, including:
- Federal Circuit affirms the Patent Trial and Appeal Board's ("PTAB")'s application of the "blocking patent" doctrine as applied to objective indicia of non-obviousness
- District court orders production of privileged documents reviewed by a Rule 30(b)(6) witness in preparation for her deposition
- More patent-busting draft legislation in the US Senate
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.